Viridian Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 12.25 M | $264.34 M | 0.09% | 15.01% |
| BLACKROCK, INC. | 11/12/2025 | 5.43 M | $117.15 M | -1.68% | 6.65% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 5.38 M | $116.11 M | 0.00% | 6.59% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 4.43 M | $95.55 M | 0.00% | 5.43% |
| VANGUARD GROUP INC | 11/07/2025 | 4.33 M | $93.48 M | -3.92% | 5.31% |
| VR ADVISER, LLC | 11/14/2025 | 3.88 M | $83.79 M | 0.00% | 4.76% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2025 | 3.46 M | $74.66 M | 0.00% | 4.24% |
| COMMODORE CAPITAL LP | 11/14/2025 | 3.20 M | $69.06 M | -34.36% | 3.92% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.84 M | $61.35 M | 0.00% | 3.48% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 2.61 M | $56.31 M | -4.82% | 3.20% |
| STATE STREET CORP | 11/14/2025 | 2.55 M | $55.12 M | 0.03% | 3.13% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 2.42 M | $52.18 M | -16.48% | 2.96% |
| NOVO HOLDINGS A/S | 11/14/2025 | 2.38 M | $51.36 M | 0.00% | 2.92% |
| MAVERICK CAPITAL LTD | 11/14/2025 | 2.21 M | $47.75 M | -1.96% | 2.71% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 1.92 M | $41.53 M | 1.14% | 2.36% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 1.86 M | $40.13 M | -4.35% | 2.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.77 M | $38.12 M | 1.47% | 2.16% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 1.74 M | $37.64 M | 0.00% | 2.14% |
| LOOMIS SAYLES & CO L P | 11/13/2025 | 1.55 M | $33.46 M | 15.83% | 1.90% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 1.46 M | $31.56 M | 226.79% | 1.79% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 1.22 M | $26.33 M | 10.06% | 1.50% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 1.20 M | $25.92 M | 135.55% | 1.47% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 1.15 M | $24.91 M | -11.11% | 1.41% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 1.12 M | $24.22 M | 314.92% | 1.38% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.05 M | $22.65 M | -17.09% | 1.29% |
| VIVO CAPITAL, LLC | 11/14/2025 | 982.58 K | $21.20 M | 0.00% | 1.20% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 937.47 K | $20.23 M | 142.28% | 1.15% |
| MARSHALL WACE, LLP | 11/13/2025 | 869.19 K | $18.76 M | -28.04% | 1.07% |
| CANDRIAM S.C.A. | 11/06/2025 | 860.23 K | $18.56 M | -0.24% | 1.05% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/16/2025 | 851.66 K | $18.38 M | 65.17% | 1.04% |
| WOODLINE PARTNERS LP | 11/14/2025 | 815.49 K | $17.60 M | 0.00% | 1.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 764.56 K | $16.50 M | -15.03% | 0.94% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2025 | 736.60 K | $15.90 M | 0.00% | 0.90% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 638.78 K | $13.79 M | 31.52% | 0.78% |
| NORTHERN TRUST CORP | 11/14/2025 | 620.86 K | $13.40 M | 4.02% | 0.76% |
| ROSALIND ADVISORS, INC. | 11/13/2025 | 600.00 K | $12.95 M | -14.29% | 0.74% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 595.36 K | $12.85 M | 3.72% | 0.73% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 500.26 K | $10.80 M | 0.00% | 0.61% |
| HIGHVISTA STRATEGIES LLC | 11/14/2025 | 469.34 K | $10.13 M | -3.14% | 0.58% |
| UBS GROUP AG | 11/13/2025 | 447.68 K | $9.66 M | -16.11% | 0.55% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 432.42 K | $9.33 M | -23.44% | 0.53% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 11/12/2025 | 423.27 K | $9.13 M | 0.00% | 0.52% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2025 | 377.71 K | $8.15 M | 7.35% | 0.46% |
| ROYAL BANK OF CANADA | 11/14/2025 | 368.60 K | $7.96 M | 6.56% | 0.45% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 344.08 K | $7.43 M | -8.69% | 0.42% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 312.76 K | $6.75 M | -5.82% | 0.38% |
| JPMORGAN CHASE & CO | 11/26/2025 | 309.13 K | $6.67 M | -25.69% | 0.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 259.51 K | $5.60 M | 100.00% | 0.32% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 250.00 K | $5.40 M | -35.90% | 0.31% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 245.76 K | $5.30 M | 6.46% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Viridian Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 205 institutional investors and hedge funds held shares of Viridian Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 12.25 M
BlackRock, Inc.: 5.43 M
Deep Track Capital, LP: 5.38 M
Kynam Capital Management, LP: 4.43 M
VANGUARD GROUP INC: 4.33 M
VR Adviser, LLC: 3.88 M
114.23% of Viridian Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 100.63 M shares in the last 24 months. This purchase volume represents approximately $3.22 B in transactions.